Home / Inspections / 1058496

FDA Inspection 1058496 — Astellas Pharma US Inc.

Astellas Pharma US Inc. — FEI 1000036852

The FDA completed an inspection of Astellas Pharma US Inc. on June 22, 2018 in Northbrook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 22, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1217117 (OAI Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108572 (VAI Fri Oct 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030399 (NAI Fri Sep 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864055 (NAI Wed Feb 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 769358 (VAI Mon Feb 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources